Australia China Endoscopy: Controlling shareholder intends to reduce its stake in the company by no more than 1.93%.

On the evening of October 31, Aohua Endoscopy announced that Gu Xiaozhou, the controlling shareholder, one of the actual controllers, a director, and the general manager of the company, plans to reduce his shareholding in the company through centralized bidding and block trading from November 24, 2025 to February 23, 2026, by no more than 2.6 million shares, or 1.93% of the total share capital of the company. Among them, the reduction through centralized bidding will not exceed 1.3466 million shares, and the reduction through block trading will not exceed 1.2534 million shares. The reduction price will be determined based on the market price at the time of the reduction, and the reason for the reduction is for personal financial needs. The implementation of this reduction plan is uncertain.